{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:23Z","timestamp":1791390023817,"version":"4.3.3"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01901-z","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:52:05Z","timestamp":1755067925000},"page":"5235-5256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The IL-12 family cytokines in neurodegenerative diseases: dual roles in neurotoxicity and neuroprotection"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-497X","authenticated-orcid":false,"given":"Pouya","family":"Goleij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantea Majma","family":"Sanaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin Khazeei","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana\u00e9 S.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"publisher","DOI":"10.1159\/000544106","author":"S Al-Shammri","year":"2025","unstructured":"Al-Shammri S, Chattopadhyay A, Raghupathy R (2025) Vitamin D supplementation mediates a shift toward anti-inflammatory cytokine response in multiple sclerosis. Med Princ Pract. https:\/\/doi.org\/10.1159\/000544106","journal-title":"Med Princ Pract"},{"key":"1901_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1606-1","volume":"16","author":"DD \u00c1lvarez-Luqu\u00edn","year":"2019","unstructured":"\u00c1lvarez-Luqu\u00edn DD, Arce-Sillas A, Leyva-Hern\u00e1ndez J, Sevilla-Reyes E, Boll MC, Montes-Moratilla E, Vivas-Almaz\u00e1n V, P\u00e9rez-Correa C, Rodr\u00edguez-Ortiz U, Espinoza-C\u00e1rdenas R (2019) Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs: other regulatory populations are also involved. J Neuroinflammation 16:1\u201311","journal-title":"J Neuroinflammation"},{"key":"1901_CR3","doi-asserted-by":"publisher","first-page":"1498288","DOI":"10.3389\/fimmu.2024.1498288","volume":"15","author":"J An","year":"2025","unstructured":"An J, Fu D, Chen X, Guan C, Li L, Bai J, Lv H (2025) Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation? Front Immunol 15:1498288","journal-title":"Front Immunol"},{"issue":"10","key":"1901_CR4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41593-023-01435-z","volume":"26","author":"M Andreadou","year":"2023","unstructured":"Andreadou M, Ingelfinger F, De Feo D, Cramer TLM, Tuzlak S, Friebel E, Schreiner B, Eede P, Schneeberger S, Geesdorf M, Ridder F, Welsh CA, Power L, Kirschenbaum D, Tyagarajan SK, Greter M, Heppner FL, Mundt S, Becher B (2023) IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat Neurosci 26(10):1701\u20131712","journal-title":"Nat Neurosci"},{"key":"1901_CR5","doi-asserted-by":"publisher","first-page":"1395921","DOI":"10.3389\/fimmu.2024.1395921","volume":"15","author":"F Andres-Martin","year":"2024","unstructured":"Andres-Martin F, James C, Catalfamo M (2024) IL-27 expression regulation and its effects on adaptive immunity against viruses. Front Immunol 15:1395921","journal-title":"Front Immunol"},{"issue":"1","key":"1901_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1567205017666200212160343","volume":"17","author":"Y Ano","year":"2020","unstructured":"Ano Y, Ikado K, Uchida K, Nakayama H (2020) Amyloid \u03b2-induced mesenteric inflammation in an Alzheimer\u2019s disease transgenic mouse model. Curr Alzheimer Res 17(1):52\u201359","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"1901_CR7","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.52711\/0974-360X.2021.00688","volume":"14","author":"J Avarachan","year":"2021","unstructured":"Avarachan J, Augustine A, Shinde PM, Gunasekaran V (2021) A mechanistic approach of peroxisome proliferator-activated receptors and its subtypes on clinical and preclinical model of neurodegenerative disorders. Res J Pharm Technol 14(7):3967\u20133975","journal-title":"Res J Pharm Technol"},{"key":"1901_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17427","author":"IS Barac","year":"2023","unstructured":"Barac IS, V\u0103c\u0103ra\u0219 V, Iancu M, Mure\u0219anu DF, Procopciuc LM (2023a) Interleukins (IL-23 and IL-27) serum levels: relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17427","journal-title":"Heliyon"},{"issue":"6","key":"1901_CR9","doi-asserted-by":"publisher","first-page":"e17427","DOI":"10.1016\/j.heliyon.2023.e17427","volume":"9","author":"IS Barac","year":"2023","unstructured":"Barac IS, V\u0103c\u0103ra\u0219 V, Iancu M, Mure\u0219anu DF, Procopciuc LM (2023b) Interleukins (IL-23 and IL-27) serum levels: relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon 9(6):e17427","journal-title":"Heliyon"},{"key":"1901_CR10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3389\/fimmu.2019.00988","volume":"10","author":"D Bastian","year":"2019","unstructured":"Bastian D, Wu Y, Betts BC, Yu X-Z (2019) The IL-12 cytokine and receptor family in graft-vs.-host disease. Front Immunol 10:988","journal-title":"Front Immunol"},{"key":"1901_CR11","doi-asserted-by":"publisher","first-page":"109894","DOI":"10.1016\/j.clim.2024.109894","volume":"259","author":"L Beckers","year":"2024","unstructured":"Beckers L, Baeten P, Popescu V, Swinnen D, Cardilli A, Hamad I, Van Wijmeersch B, Tavernier SJ, Kleinewietfeld M, Broux B, Fraussen J, Somers V (2024) Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab. Clin Immunol 259:109894","journal-title":"Clin Immunol"},{"issue":"8","key":"1901_CR12","doi-asserted-by":"publisher","first-page":"e209928","DOI":"10.1212\/WNL.0000000000209928","volume":"103","author":"E Benarroch","year":"2024","unstructured":"Benarroch E (2024) What is the role of cytokines in synaptic transmission? Neurology 103(8):e209928","journal-title":"Neurology"},{"issue":"2","key":"1901_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10787-024-01598-6","volume":"33","author":"V Bhardwaj","year":"2025","unstructured":"Bhardwaj V, Kumari S, Dhapola R, Sharma P, Beura SK, Singh SK, Vellingiri B, HariKrishnaReddy D (2025) Shedding light on microglial dysregulation in Alzheimer\u2019s disease: exploring molecular mechanisms and therapeutic avenues. Inflammopharmacology 33(2):679\u2013702","journal-title":"Inflammopharmacology"},{"issue":"1","key":"1901_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.gastro.2024.05.036","volume":"168","author":"AR Bourgonje","year":"2024","unstructured":"Bourgonje AR, Ungaro RC, Mehandru S, Colombel JF (2024) Targeting the IL-23 pathway in inflammatory bowel disease. Gastroenterology 168(1):29\u201352","journal-title":"Gastroenterology"},{"issue":"9","key":"1901_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","volume":"15","author":"F Bright","year":"2019","unstructured":"Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M (2019) Neuroinflammation in frontotemporal dementia. Nat Rev Neurol 15(9):540\u2013555","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1901_CR16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/JLB.3MA0520-054R","volume":"108","author":"MA Cassatella","year":"2020","unstructured":"Cassatella MA, Gardiman E, Arruda-Silva F, Bianchetto-Aguilera F, Gasperini S, Bugatti M, Vermi W, Larousserie F, Devergne O, Tamassia N (2020) Human neutrophils activated by TLR8 agonists, with or without IFN\u03b3, synthesize and release EBI3, but not IL-12, IL-27, IL-35, or IL-39. J Leukoc Biol 108(5):1515\u20131526","journal-title":"J Leukoc Biol"},{"issue":"12","key":"1901_CR17","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1084\/jem.20060244","volume":"203","author":"JR Chan","year":"2006","unstructured":"Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2\u2013dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203(12):2577\u20132587","journal-title":"J Exp Med"},{"issue":"11","key":"1901_CR18","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.3390\/ijms25115803","volume":"25","author":"Z Chen","year":"2024","unstructured":"Chen Z, Balachandran YL, Chong WP, Chan KW (2024) Roles of cytokines in Alzheimer\u2019s disease. Int J Mol Sci 25(11):5803","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1901_CR19","doi-asserted-by":"publisher","first-page":"166607","DOI":"10.1016\/j.jmb.2020.07.019","volume":"433","author":"JK Choi","year":"2021","unstructured":"Choi JK, Egwuagu CE (2021) Interleukin 35 regulatory B cells. J Mol Biol 433(1):166607","journal-title":"J Mol Biol"},{"key":"1901_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12016-015-8468-9","volume":"49","author":"J Choi","year":"2015","unstructured":"Choi J, Leung PS, Bowlus C, Gershwin ME (2015) IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol 49:327\u2013332","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1901_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12974-023-02746-5","volume":"20","author":"M Chu","year":"2023","unstructured":"Chu M, Wen L, Jiang D, Liu L, Nan H, Yue A, Wang Y, Wang Y, Qu M, Wang N (2023) Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures. J Neuroinflammation 20(1):65","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1901_CR22","doi-asserted-by":"publisher","first-page":"e1262","DOI":"10.1002\/cti2.1262","volume":"10","author":"ML Cl\u00e9net","year":"2021","unstructured":"Cl\u00e9net ML, Laurent C, Lemaitre F, Farzam-kia N, Tastet O, Devergne O, Lahav B, Girard M, Duquette P, Prat A (2021) The IL-27\/IL-27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients. Clin Trans Immunol 10(3):e1262","journal-title":"Clin Trans Immunol"},{"issue":"1","key":"1901_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","volume":"226","author":"LW Collison","year":"2008","unstructured":"Collison LW, Vignali DA (2008) Interleukin-35: odd one out or part of the family? Immunol Rev 226(1):248\u2013262","journal-title":"Immunol Rev"},{"issue":"9","key":"1901_CR24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/biomedicines10092062","volume":"10","author":"MA Dias de Sousa","year":"2022","unstructured":"Dias de Sousa MA, Desid\u00e9rio CS, da Silva Catarino J, Trevisan RO, Alves da Silva DA, Rocha VFR, Bovi WG, Timoteo RP, Bonatti RCF, da Silva AE (2022) Role of cytokines, chemokines and IFN-\u03b3+ IL-17+ double-positive CD4+ T cells in patients with multiple sclerosis. Biomedicines 10(9):2062","journal-title":"Biomedicines"},{"issue":"10","key":"1901_CR25","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.3390\/cimb46100686","volume":"46","author":"C Dong","year":"2024","unstructured":"Dong C, Tan D, Sun H, Li Z, Zhang L, Zheng Y, Liu S, Zhang Y, He Q (2024) Interleukin-12 delivery strategies and advances in tumor immunotherapy. Curr Issues Mol Biol 46(10):11548\u201311579","journal-title":"Curr Issues Mol Biol"},{"key":"1901_CR26","unstructured":"Duffy, S. (2018). The role of regulatory T cells and interleukin-35 in pain associated with an animal model of multiple sclerosis, UNSW Sydney"},{"key":"1901_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/NS20220063","author":"N Dzamko","year":"2023","unstructured":"Dzamko N (2023) Cytokine activity in Parkinson\u2019s disease. Neuronal Signaling. https:\/\/doi.org\/10.1042\/NS20220063","journal-title":"Neuronal Signaling"},{"issue":"3","key":"1901_CR28","doi-asserted-by":"publisher","first-page":"e48530","DOI":"10.15252\/embr.201948530","volume":"21","author":"P Eede","year":"2020","unstructured":"Eede P, Obst J, Benke E, Yvon-Durocher G, Richard BC, Gimber N, Schmoranzer J, B\u00f6ddrich A, Wanker EE, Prokop S (2020) Interleukin-12\/23 deficiency differentially affects pathology in male and female Alzheimer\u2019s disease-like mice. EMBO Rep 21(3):e48530","journal-title":"EMBO Rep"},{"issue":"1","key":"1901_CR29","first-page":"541259","volume":"2013","author":"G Ellrichmann","year":"2013","unstructured":"Ellrichmann G, Reick C, Saft C, Linker RA (2013) The role of the immune system in Huntington\u2019s disease. J Immunol Res 2013(1):541259","journal-title":"J Immunol Res"},{"issue":"4","key":"1901_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/biom15040473","volume":"15","author":"PA Erichsen","year":"2025","unstructured":"Erichsen PA, Henriksen EE, Nielsen JE, Ejlerskov P, Simonsen AH, Toft A (2025) Immunological fluid biomarkers in frontotemporal dementia: a systematic review. Biomolecules 15(4):473","journal-title":"Biomolecules"},{"issue":"1","key":"1901_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","volume":"19","author":"J Fu","year":"2022","unstructured":"Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X (2022) The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J Neuroinflammation 19(1):98","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1901_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40264-022-01184-1","volume":"45","author":"A Gaimari","year":"2022","unstructured":"Gaimari A, Fusaroli M, Raschi E, Baldin E, Vignatelli L, Nonino F, De Ponti F, Mandrioli J, Poluzzi E (2022) Amyotrophic lateral sclerosis as an adverse drug reaction: a disproportionality analysis of the food and drug administration adverse event reporting system. Drug Saf 45(6):663\u2013673","journal-title":"Drug Saf"},{"issue":"2","key":"1901_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/jpm11020066","volume":"11","author":"M Ga\u0142ecka","year":"2021","unstructured":"Ga\u0142ecka M, Bli\u017aniewska-Kowalska K, Orzechowska A, Szemraj J, Maes M, Berk M, Su K-P, Ga\u0142ecki P (2021) Inflammatory versus anti-inflammatory profiles in major depressive disorders\u2014the role of IL-17, IL-21, IL-23, IL-35 and Foxp3. J Pers Med 11(2):66","journal-title":"J Pers Med"},{"key":"1901_CR34","doi-asserted-by":"publisher","first-page":"108974","DOI":"10.1016\/j.fsi.2023.108974","volume":"140","author":"H Gao","year":"2023","unstructured":"Gao H, Li K, Ai K, Geng M, Cao Y, Wang D, Yang J, Wei X (2023) Interleukin-12 induces IFN-\u03b3 secretion and STAT signaling implying its potential regulation of Th1 cell response in Nile tilapia. Fish Shellfish Immunol 140:108974","journal-title":"Fish Shellfish Immunol"},{"issue":"4","key":"1901_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biology14040347","volume":"14","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez M (2025) The role of IL-23 in the development of inflammatory diseases. Biol 14(4):347","journal-title":"Biol"},{"issue":"3","key":"1901_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00210-022-02357-6","volume":"396","author":"AS Gautam","year":"2023","unstructured":"Gautam AS, Pulivarthi Cb, Singh RK (2023) Proinflammatory IL-17 levels in serum\/cerebrospinal fluid of patients with neurodegenerative diseases: a meta-analysis study. Naunyn Schmiedebergs Arch Pharmacol 396(3):577\u2013588","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1901_CR37","doi-asserted-by":"publisher","first-page":"108546","DOI":"10.1016\/j.intimp.2022.108546","volume":"105","author":"EA Gaviglio","year":"2022","unstructured":"Gaviglio EA, Peralta Ramos JM, Arroyo DS, Bussi C, Iribarren P, Rodriguez-Galan MC (2022a) Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-\u03b3-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain. Int Immunopharmacol 105:108546","journal-title":"Int Immunopharmacol"},{"key":"1901_CR38","doi-asserted-by":"publisher","first-page":"108546","DOI":"10.1016\/j.intimp.2022.108546","volume":"105","author":"EA Gaviglio","year":"2022","unstructured":"Gaviglio EA, Ramos JMP, Arroyo DS, Bussi C, Iribarren P, Rodriguez-Galan MC (2022b) Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-\u03b3-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain. Int Immunopharmacol 105:108546","journal-title":"Int Immunopharmacol"},{"key":"1901_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, M\u00f6ller T, Biber K (2021) Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol 141:681\u2013696","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1901_CR40","doi-asserted-by":"publisher","first-page":"e14238","DOI":"10.1111\/ijcp.14238","volume":"75","author":"H Gezmis","year":"2021","unstructured":"Gezmis H, Doran T, MaydaDomac F, Yucel D, Karaci R, Kirac D (2021) CD4+ and CD25+ T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients. Int J Clin Pract 75(7):e14238","journal-title":"Int J Clin Pract"},{"issue":"1","key":"1901_CR41","first-page":"15","volume":"16","author":"SA Ghaffari","year":"2017","unstructured":"Ghaffari SA, Nemati M, Hajghani H, Ebrahimi H, Sheikhi A, Jafarzadeh A (2017) Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms. Iran J Neurol 16(1):15","journal-title":"Iran J Neurol"},{"key":"1901_CR42","doi-asserted-by":"publisher","first-page":"114399","DOI":"10.1016\/j.intimp.2025.114399","volume":"152","author":"P Goleij","year":"2025","unstructured":"Goleij P, Amini A, Tabari MAK, Hadipour M, Rezaee A, Daglia M, Aschner M, Sanaye PM, Kumar AP, Khan H (2025) Unraveling the role of the IL-20 cytokine family in neurodegenerative diseases: mechanisms and therapeutic insights. Int Immunopharmacol 152:114399","journal-title":"Int Immunopharmacol"},{"key":"1901_CR43","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s10067-013-2341-0","volume":"32","author":"F Gong","year":"2013","unstructured":"Gong F, Pan Y-H, Huang X, Chen J, Xiao J-H, Zhu H-Y (2013) Interleukin-27 as a potential therapeutic target for rheumatoid arthritis: has the time come? Clin Rheumatol 32:1425\u20131428","journal-title":"Clin Rheumatol"},{"key":"1901_CR44","doi-asserted-by":"publisher","first-page":"782935","DOI":"10.3389\/fimmu.2021.782935","volume":"12","author":"K Hendrawan","year":"2021","unstructured":"Hendrawan K, Khoo MLM, Visweswaran M, Massey JC, Withers B, Sutton I, Ma DDF, Moore JJ (2021) Long-term suppression of circulating proinflammatory cytokines in multiple sclerosis patients following autologous haematopoietic stem cell transplantation. Front Immunol 12:782935","journal-title":"Front Immunol"},{"key":"1901_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fcell.2020.00210","volume":"8","author":"A Hu","year":"2020","unstructured":"Hu A, Ding M, Zhu J, Liu J-Q, Pan X, Ghoshal K, Bai X-F (2020) Intra-tumoral delivery of IL-27 using adeno-associated virus stimulates anti-tumor immunity and enhances the efficacy of immunotherapy. Front Cell Dev Biol 8:210","journal-title":"Front Cell Dev Biol"},{"key":"1901_CR46","doi-asserted-by":"publisher","first-page":"709229","DOI":"10.3389\/fimmu.2021.709229","volume":"12","author":"D Huang","year":"2021","unstructured":"Huang D, Ran Y, Liu Z, He J, Yin N, Qi H (2021) IL-27 mediates pro-inflammatory effects via the ERK signaling pathway during preterm labor. Front Immunol 12:709229","journal-title":"Front Immunol"},{"issue":"1","key":"1901_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","volume":"74","author":"F Jadidi-Niaragh","year":"2011","unstructured":"Jadidi-Niaragh F, Mirshafiey A (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74(1):1\u201313","journal-title":"Scand J Immunol"},{"issue":"4","key":"1901_CR48","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s12031-014-0443-z","volume":"55","author":"A Jafarzadeh","year":"2015","unstructured":"Jafarzadeh A, Jamali M, Mahdavi R, Ebrahimi HA, Hajghani H, Khosravimashizi A, Nemati M, Najafipour H, Sheikhi A, Mohammadi MM (2015) Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program. J Mol Neurosci 55(4):891\u2013897","journal-title":"J Mol Neurosci"},{"key":"1901_CR49","doi-asserted-by":"publisher","first-page":"1088124","DOI":"10.3389\/fimmu.2022.1088124","volume":"13","author":"Q Jia","year":"2022","unstructured":"Jia Q, Li S, Li X-J, Yin P (2022) Neuroinflammation in Huntington\u2019s disease: from animal models to clinical therapeutics. Front Immunol 13:1088124","journal-title":"Front Immunol"},{"key":"1901_CR50","doi-asserted-by":"publisher","first-page":"1059994","DOI":"10.3389\/fimmu.2022.1059994","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Wang Z, Wei X, Yu X-F (2022) Inflammatory checkpoints in amyotrophic lateral sclerosis: from biomarkers to therapeutic targets. Front Immunol 13:1059994","journal-title":"Front Immunol"},{"key":"1901_CR51","doi-asserted-by":"publisher","first-page":"1072420","DOI":"10.3389\/fimmu.2022.1072420","volume":"13","author":"Q Jouhault","year":"2023","unstructured":"Jouhault Q, Cherqaoui B, Jobart-Malfait A, Glatigny S, Lauraine M, Hulot A, Morelle G, Hagege B, Ermoza K, El Marjou A (2023) Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses. Front Immunol 13:1072420","journal-title":"Front Immunol"},{"key":"1901_CR52","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3389\/fimmu.2020.01051","volume":"11","author":"M Kang","year":"2020","unstructured":"Kang M, Choi JK, Jittayasothorn Y, Egwuagu CE (2020) Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune uveitis. Front Immunol 11:1051","journal-title":"Front Immunol"},{"issue":"9","key":"1901_CR53","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1185\/030079906X120931","volume":"22","author":"LH Kasper","year":"2006","unstructured":"Kasper LH, Everitt D, Leist TP, Ryan KA, Mascelli MA, Johnson K, Raychaudhuri A, Vollmer T (2006) A phase I trial of an interleukin-12\/23 monoclonal antibody in relapsing multiple sclerosis. Curr Med Res Opin 22(9):1671\u20131678","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1901_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cen3.12005","volume":"4","author":"J Kawanokuchi","year":"2013","unstructured":"Kawanokuchi J, Takeuchi H, Sonobe Y, Mizuno T, Suzumura A (2013) Interleukin-27 promotes inflammatory and neuroprotective responses in microglia. Clin Exp Neuroimmunol 4(1):36\u201345","journal-title":"Clin Exp Neuroimmunol"},{"key":"1901_CR55","doi-asserted-by":"crossref","unstructured":"Kennedy, R. H. and R. Silver (2022). Neuroimmune signaling: cytokines and the central nervous system. Neuroscience in the 21st century: from basic to clinical, Springer: 883\u2013922.","DOI":"10.1007\/978-3-030-88832-9_174"},{"key":"1901_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","volume":"166","author":"E Kouchaki","year":"2018","unstructured":"Kouchaki E, Kakhaki RD, Tamtaji OR, Dadgostar E, Behnam M, Nikoueinejad H, Akbari H (2018) Increased serum levels of TNF-\u03b1 and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg 166:76\u201379","journal-title":"Clin Neurol Neurosurg"},{"key":"1901_CR57","doi-asserted-by":"publisher","first-page":"1331217","DOI":"10.3389\/fimmu.2024.1331217","volume":"15","author":"JG Krueger","year":"2024","unstructured":"Krueger JG, Eyerich K, Kuchroo VK, Ritchlin CT, Abreu MT, Elloso MM, Fourie A, Fakharzadeh S, Sherlock JP, Yang Y-W (2024) IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy. Front Immunol 15:1331217","journal-title":"Front Immunol"},{"issue":"1","key":"1901_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42","journal-title":"Transl Neurodegener"},{"issue":"13","key":"1901_CR59","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.3390\/ijms23137273","volume":"23","author":"TS Leyane","year":"2022","unstructured":"Leyane TS, Jere SW, Houreld NN (2022) Oxidative stress in ageing and chronic degenerative pathologies: molecular mechanisms involved in counteracting oxidative stress and chronic inflammation. Int J Mol Sci 23(13):7273","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1901_CR60","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/brain\/awl273","volume":"130","author":"Y Li","year":"2007","unstructured":"Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang G-X (2007) Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 130(2):490\u2013501","journal-title":"Brain"},{"key":"1901_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071580","author":"M Lis","year":"2024","unstructured":"Lis M, Niedziela N, Adamczyk-Zostawa J, Wierzbicki K, Czuba Z, Zalejska-Fiolka J, Bartman W, \u015awi\u0119tek A, Adamczyk-Sowa M (2024) Can vitamin D supplementation improve inflammation in relapsing-remitting multiple sclerosis patients? Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12071580","journal-title":"Biomedicines"},{"issue":"11","key":"1901_CR62","first-page":"3565","volume":"10","author":"J-Q Liu","year":"2020","unstructured":"Liu J-Q, Zhu J, Hu A, Zhang A, Yang C, Yu J, Ghoshal K, Basu S, Bai X-F (2020a) Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? Am J Cancer Res 10(11):3565","journal-title":"Am J Cancer Res"},{"key":"1901_CR63","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","volume":"11","author":"L-R Liu","year":"2020","unstructured":"Liu L-R, Liu J-C, Bao J-S, Bai Q-Q, Wang G-Q (2020b) Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol 11:1024","journal-title":"Front Immunol"},{"key":"1901_CR64","doi-asserted-by":"publisher","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Li S, Ying S, Tang S, Ding Y, Li Y, Qiao J, Fang H (2020c) The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front Immunol 11:594735","journal-title":"Front Immunol"},{"key":"1901_CR65","doi-asserted-by":"publisher","first-page":"683332","DOI":"10.3389\/fimmu.2021.683332","volume":"12","author":"K Liu","year":"2021","unstructured":"Liu K, Huang A, Nie J, Tan J, Xing S, Qu Y, Jiang K (2021) IL-35 regulates the function of immune cells in tumor microenvironment. Front Immunol 12:683332","journal-title":"Front Immunol"},{"key":"1901_CR66","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS11586","author":"JA Livingston","year":"2024","unstructured":"Livingston JA, Ragoonanan D, Tewari P, Gill JB, Banck S, Gao M, Lin HY, Li Y, Xia X, Hu J (2024) A first-in-human phase 1 trial of T cell membrane-anchored tumor targeted IL12 (ATTIL12)-T cell therapy in advanced\/metastatic soft tissue and bone sarcoma. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.TPS11586","journal-title":"J Clin Oncol"},{"issue":"1","key":"1901_CR67","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1038\/s41598-023-35945-4","volume":"13","author":"HC Lok","year":"2023","unstructured":"Lok HC, Katzeff JS, Hodges JR, Piguet O, Fu Y, Halliday GM, Kim WS (2023) Elevated GRO-\u03b1 and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia. Sci Rep 13(1):8942","journal-title":"Sci Rep"},{"issue":"3","key":"1901_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14737175.9.3.319","volume":"9","author":"EE Longbrake","year":"2009","unstructured":"Longbrake EE, Racke MK (2009) Why did IL-12\/IL-23 antibody therapy fail in multiple sclerosis? Expert Rev Neurother 9(3):319\u2013321","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"1901_CR69","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s12031-021-01802-0","volume":"71","author":"C Luo","year":"2021","unstructured":"Luo C, Li B, Chen L, Zhao L, Wei Y (2021) IL-27 protects the brain from ischemia-reperfusion injury via the gp130\/STAT3 signaling pathway. J Mol Neurosci 71(9):1838\u20131848","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1901_CR70","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00436-021-07204-w","volume":"120","author":"S Mahmoudzadeh","year":"2021","unstructured":"Mahmoudzadeh S, Nozad Charoudeh H, Marques CS, Bahadory S, Ahmadpour E (2021) The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review. Parasitol Res 120(7):2303\u20132309","journal-title":"Parasitol Res"},{"issue":"Supplement_2","key":"1901_CR71","doi-asserted-by":"publisher","first-page":"ii42","DOI":"10.1093\/ecco-jcc\/jjac038","volume":"16","author":"BD McDonald","year":"2022","unstructured":"McDonald BD, Dyer EC, Rubin DT (2022) IL-23 monoclonal antibodies for IBD: so many, so different? J Crohns Colitis 16(Supplement_2):ii42\u2013ii53","journal-title":"J Crohns Colitis"},{"issue":"1","key":"1901_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/jiaa064","volume":"222","author":"A Mehrotra","year":"2020","unstructured":"Mehrotra A, D\u2019Angelo JA, Romney-Vanterpool A, Chu T, Bertoletti A, Janssen HL, Gehring AJ (2020) IFN-\u03b1 suppresses myeloid cytokine production, impairing IL-12 production and the ability to support T-cell proliferation. J Infect Dis 222(1):148\u2013157","journal-title":"J Infect Dis"},{"key":"1901_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01592-y","author":"Y Mei","year":"2022","unstructured":"Mei Y, Ran Y, Liu Z, Zhou Y, He J, Yin N, Qi H (2022) The role of IL-27 in the systemic inflammatory response that accompanies preterm labour. Inflammation. https:\/\/doi.org\/10.1007\/s10753-021-01592-y","journal-title":"Inflammation"},{"key":"1901_CR74","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic J, Arsenijevic A, Stojanovic B, Kanjevac T, Arsenijevic D, Radosavljevic G, Milovanovic M, Arsenijevic N (2020) Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol 11:947","journal-title":"Front Immunol"},{"key":"1901_CR75","doi-asserted-by":"publisher","first-page":"1277399","DOI":"10.3389\/fnins.2023.1277399","volume":"17","author":"S Mimic","year":"2023","unstructured":"Mimic S, Aru B, Pehlivano\u011flu C, Sleiman H, Andjus PR, Yan\u0131kkaya Demirel G (2023) Immunology of amyotrophic lateral sclerosis\u2013role of the innate and adaptive immunity. Front Neurosci 17:1277399","journal-title":"Front Neurosci"},{"issue":"2","key":"1901_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers13020167","volume":"13","author":"B Mirlekar","year":"2021","unstructured":"Mirlekar B, Pylayeva-Gupta Y (2021) IL-12 family cytokines in cancer and immunotherapy. Cancers 13(2):167","journal-title":"Cancers"},{"key":"1901_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mehy.2017.09.017","volume":"109","author":"S Moghadam","year":"2017","unstructured":"Moghadam S, Erfanmanesh M, Esmaeilzadeh A (2017) Interleukin 35 and hepatocyte growth factor; as a novel combined immune gene therapy for multiple sclerosis disease. Med Hypotheses 109:102\u2013105","journal-title":"Med Hypotheses"},{"key":"1901_CR78","doi-asserted-by":"publisher","first-page":"654739","DOI":"10.3389\/fneur.2021.654739","volume":"12","author":"I Mortada","year":"2021","unstructured":"Mortada I, Farah R, Nabha S, Ojcius DM, Fares Y, Almawi WY, Sadier NS (2021) Immunotherapies for neurodegenerative diseases. Front Neurol 12:654739","journal-title":"Front Neurol"},{"issue":"3","key":"1901_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","volume":"16","author":"AR Moschen","year":"2019","unstructured":"Moschen AR, Tilg H, Raine T (2019) IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat Rev Gastroenterol Hepatol 16(3):185\u2013196","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1901_CR80","doi-asserted-by":"publisher","first-page":"e010685","DOI":"10.1136\/jitc-2024-010685","volume":"13","author":"A Nash","year":"2025","unstructured":"Nash A, DeBonis J, Murungi D, Castillo B, Kim B, Hu F, Chambers C, Nguyen A, Hernandez A, Wang Z (2025) IL-12-producing cytokine factories induce precursor exhausted T cells and elimination of primary and metastatic tumors. J Immunother Cancer 13(4):e010685","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1901_CR81","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/ard-2022-223506","volume":"82","author":"D Nikolopoulos","year":"2023","unstructured":"Nikolopoulos D, Manolakou T, Polissidis A, Filia A, Bertsias G, Koutmani Y, Boumpas DT (2023) Microglia activation in the presence of intact blood\u2013brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus. Ann Rheum Dis 82(5):646\u2013657","journal-title":"Ann Rheum Dis"},{"key":"1901_CR82","doi-asserted-by":"publisher","first-page":"639353","DOI":"10.3389\/fneur.2021.639353","volume":"12","author":"L Nitsch","year":"2021","unstructured":"Nitsch L, Schneider L, Zimmermann J, M\u00fcller M (2021) Microglia-derived interleukin 23: a crucial cytokine in Alzheimer\u2019s disease? Front Neurol 12:639353","journal-title":"Front Neurol"},{"issue":"10","key":"1901_CR83","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.4103\/1673-5374.336134","volume":"17","author":"AN Nortey","year":"2022","unstructured":"Nortey AN, Garces KN, Hackam AS (2022) Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases. Neural Regen Res 17(10):2149\u20132152","journal-title":"Neural Regen Res"},{"key":"1901_CR84","unstructured":"Obst, J. (2017). Influence of IL-12\/IL-23 signaling on Alzheimer\u2019s disease \u03b2-amyloid pathology."},{"key":"1901_CR85","doi-asserted-by":"crossref","unstructured":"Papargyris, L., Q. Glaziou, L. Basset, S. d\u2019Almeida, P. Pignon, N. Jabrane-Ferrat, C. Blanquart, Y. Delneste and J. Tabiasco (2024). IL-27 neutralization to modulate the tumor microenvironment and increase immune checkpoint immunotherapy efficacy. bioRxiv: 2024.2009. 2013.612803","DOI":"10.1101\/2024.09.13.612803"},{"issue":"1","key":"1901_CR86","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1038\/s41467-022-33331-8","volume":"13","author":"P Pavlidis","year":"2022","unstructured":"Pavlidis P, Tsakmaki A, Pantazi E, Li K, Cozzetto D, Digby-Bell J, Yang F, Lo JW, Alberts E, Sa ACC (2022) Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. Nat Commun 13(1):5820","journal-title":"Nat Commun"},{"key":"1901_CR87","doi-asserted-by":"crossref","unstructured":"Pourgholaminejad, A. and F. Tahmasebinia (2025). Th17-Mediated Immune Responses in Pathogenesis of Neuroinflammatory. Neuroimmune Diseases: From Cells to the Living Brain: 105","DOI":"10.1007\/978-3-031-60006-7_3"},{"issue":"7","key":"1901_CR88","doi-asserted-by":"publisher","first-page":"FSO588","DOI":"10.2144\/fsoa-2020-0032","volume":"6","author":"JM Povroznik","year":"2020","unstructured":"Povroznik JM, Robinson CM (2020) IL-27 regulation of innate immunity and control of microbial growth. Future Sci OA 6(7):FSO588","journal-title":"Future Sci OA"},{"issue":"8","key":"1901_CR89","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s11011-022-01083-5","volume":"37","author":"S Reiszadeh-Jahromi","year":"2022","unstructured":"Reiszadeh-Jahromi S, Haddadi M, Mousavi P, Sanadgol N (2022) Prophylactic effects of cucurbitacin B in the EAE model of multiple sclerosis by adjustment of STAT3\/IL-23\/IL-17 axis and improvement of neuropsychological symptoms. Metab Brain Dis 37(8):2937\u20132953","journal-title":"Metab Brain Dis"},{"issue":"2","key":"1901_CR90","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2006.05.063","volume":"249","author":"M Rentzos","year":"2006","unstructured":"Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A, Tsoutsou A, Vassilopoulos D (2006) Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer\u2019s disease and frontotemporal dementia. J Neurol Sci 249(2):110\u2013114","journal-title":"J Neurol Sci"},{"issue":"1","key":"1901_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.coc.0000046300.88847.BF","volume":"27","author":"T Rich","year":"2004","unstructured":"Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr., Safran H, Wanebo HJ (2004) Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol 27(1):51\u201356","journal-title":"Am J Clin Oncol"},{"key":"1901_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2025.2498539","author":"NP Rocha","year":"2025","unstructured":"Rocha NP, Furr-Stimming E, Teixeira AL (2025) Cytokines as biomarkers of Huntington\u2019s disease progression. Expert Rev Mol Diagn. https:\/\/doi.org\/10.1080\/14737159.2025.2498539","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"1901_CR93","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/brain\/awac086","volume":"145","author":"AE Rosser","year":"2022","unstructured":"Rosser AE, Busse ME, Gray WP, Badin RA, Perrier AL, Wheelock V, Cozzi E, Martin UP, Salado-Manzano C, Mills LJ (2022) Translating cell therapies for neurodegenerative diseases: Huntington\u2019s disease as a model disorder. Brain 145(5):1584\u20131597","journal-title":"Brain"},{"key":"1901_CR94","doi-asserted-by":"publisher","first-page":"115697","DOI":"10.1016\/j.taap.2021.115697","volume":"429","author":"MA Salem","year":"2021","unstructured":"Salem MA, Budzy\u0144ska B, Kowalczyk J, El Sayed NS, Mansour SM (2021) Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer\u2019s disease in mice via modulating neuroinflammation, PI3K\/Akt, Wnt\/\u03b2-catenin, AMPK\/mTOR signaling pathways. Toxicol Appl Pharmacol 429:115697","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"1901_CR95","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/jir.2015.0015","volume":"35","author":"DV Sawant","year":"2015","unstructured":"Sawant DV, Hamilton K, Vignali DA (2015) Interleukin-35: expanding its job profile. J Interferon Cytokine Res 35(7):499\u2013512","journal-title":"J Interferon Cytokine Res"},{"key":"1901_CR96","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F, Guggino G (2021) Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol 12:637829","journal-title":"Front Immunol"},{"key":"1901_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00816-2","author":"S Schneeberger","year":"2025","unstructured":"Schneeberger S, Kim SJ, Geesdorf MN, Friebel E, Eede P, Jendrach M, Boltengagen A, Braeuning C, Ruhwedel T, H\u00fclsmeier AJ (2025a) Interleukin-12 signaling drives Alzheimer\u2019s disease pathology through disrupting neuronal and oligodendrocyte homeostasis. Nat Aging. https:\/\/doi.org\/10.1038\/s43587-025-00816-2","journal-title":"Nat Aging"},{"issue":"4","key":"1901_CR98","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s43587-025-00816-2","volume":"5","author":"S Schneeberger","year":"2025","unstructured":"Schneeberger S, Kim SJ, Geesdorf MN, Friebel E, Eede P, Jendrach M, Boltengagen A, Braeuning C, Ruhwedel T, H\u00fclsmeier AJ, Gimber N, Foerster M, Obst J, Andreadou M, Mundt S, Schmoranzer J, Prokop S, Kessler W, Kuhlmann T, M\u00f6bius W, Nave K-A, Hornemann T, Becher B, Edgar JM, Karaiskos N, Kocks C, Rajewsky N, Heppner FL (2025b) Interleukin-12 signaling drives Alzheimer\u2019s disease pathology through disrupting neuronal and oligodendrocyte homeostasis. Nat Aging 5(4):622\u2013641","journal-title":"Nat Aging"},{"issue":"9","key":"1901_CR99","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1474-4422(08)70173-X","volume":"7","author":"BM Segal","year":"2008","unstructured":"Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH (2008) Repeated subcutaneous injections of IL12\/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 7(9):796\u2013804","journal-title":"Lancet Neurol"},{"issue":"4","key":"1901_CR100","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/glia.22948","volume":"64","author":"V S\u00e9n\u00e9cal","year":"2016","unstructured":"S\u00e9n\u00e9cal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, Moore CS, Prat A, Antel J, Arbour N (2016) Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses. Glia 64(4):553\u2013569","journal-title":"Glia"},{"issue":"Supplement_2","key":"1901_CR101","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","volume":"16","author":"GW Sewell","year":"2022","unstructured":"Sewell GW, Kaser A (2022) Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention. J Crohns Colitis 16(Supplement_2):ii3\u2013ii19","journal-title":"J Crohns Colitis"},{"key":"1901_CR102","doi-asserted-by":"publisher","first-page":"106538","DOI":"10.1016\/j.intimp.2020.106538","volume":"84","author":"A Shahi","year":"2020","unstructured":"Shahi A, Afzali S, Salehi S, Aslani S, Mahmoudi M, Jamshidi A, Amirzargar A (2020) IL-27 and autoimmune rheumatologic diseases: the good, the bad, and the ugly. Int Immunopharmacol 84:106538","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1901_CR103","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","volume":"14","author":"A Sharma","year":"2022","unstructured":"Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK (2022) IL-23\/Th17 axis: a potential therapeutic target of psoriasis. Curr Drug Res Rev Formerly 14(1):24\u201336","journal-title":"Curr Drug Res Rev Formerly"},{"issue":"2","key":"1901_CR104","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/00207454.2023.2292951","volume":"135","author":"S Shateri","year":"2025","unstructured":"Shateri S, Hossein KS, Alireza HT, Shima R, Meisam M, Somayeh MB, Gholam-Ali S, Hossein HA, Vajiheh A, Babak G, Lily S, Alireza D, Farzaneh S, Abbas T, Aliasghar K, Reza SM, Karima S (2025a) Plasma cytokines profile in patients with Alzheimer\u2019s and Parkinson\u2019s disease: a comparative study in terms of inflammation. Int J Neurosci 135(2):158\u2013167","journal-title":"Int J Neurosci"},{"issue":"2","key":"1901_CR105","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/00207454.2023.2292951","volume":"135","author":"S Shateri","year":"2025","unstructured":"Shateri S, Khatami SH, Haghbin Toutounchi A, Rajaei S, Mahdavi M, Mahmoodi Baram S, Shahidi G-A, Habibi AH, Aghamollaii V, Ghlichnia B (2025b) Plasma cytokines profile in patients with Alzheimer\u2019s and Parkinson\u2019s disease: a comparative study in terms of inflammation. Int J Neurosci 135(2):158\u2013167","journal-title":"Int J Neurosci"},{"issue":"31","key":"1901_CR106","doi-asserted-by":"publisher","first-page":"e21390","DOI":"10.1097\/MD.0000000000021390","volume":"99","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zhang S, Xue Y, Yang Z, Lin Y, Liu L, Liu H (2020) IL-35 polymorphisms and cognitive decline did not show any association in patients with coronary heart disease over a 2-year period: a retrospective observational study (STROBE compliant). Medicine (Baltimore) 99(31):e21390","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1901_CR107","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/ijms24010641","volume":"24","author":"AM Soliman","year":"2022","unstructured":"Soliman AM, Barreda DR (2022) Acute inflammation in tissue healing. Int J Mol Sci 24(1):641","journal-title":"Int J Mol Sci"},{"key":"1901_CR108","doi-asserted-by":"crossref","unstructured":"Soltani, M., P. Beshkar, K. Mokhtarian, M. Anjomshoa, M. M. Rezaei, F. Azadegan-Dehkordi, Y. Mirzaei, J. Majidi and N. Bagheri (2022). A study of autoantibodies against some central nervous system antigens and the il-35 serum level in schizophrenia. Iranian Journal of Allergy, Asthma and Immunology.","DOI":"10.18502\/ijaai.v21i4.10291"},{"issue":"8","key":"1901_CR109","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.3390\/ijms26083854","volume":"26","author":"C Stacchiotti","year":"2025","unstructured":"Stacchiotti C, Mazzella di Regnella S, Cinotti M, Spalloni A, Volpe E (2025) Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies. Int J Mol Sci 26(8):3854","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1901_CR110","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.imlet.2008.01.011","volume":"117","author":"J Stumhofer","year":"2008","unstructured":"Stumhofer J, Hunter C (2008) Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 117(2):123\u2013130","journal-title":"Immunol Lett"},{"issue":"2","key":"1901_CR111","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","volume":"75","author":"L Sun","year":"2015","unstructured":"Sun L, He C, Nair L, Yeung J, Egwuagu CE (2015) Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75(2):249\u2013255","journal-title":"Cytokine"},{"issue":"1","key":"1901_CR112","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00018-024-05402-0","volume":"81","author":"X Sun","year":"2024","unstructured":"Sun X, Gu R, Bai J (2024) Differentiation and regulation of CD4+ T cell subsets in Parkinson\u2019s disease. Cell Mol Life Sci 81(1):352","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1901_CR113","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1002\/iid3.766","volume":"11","author":"MJ Tavaf","year":"2023","unstructured":"Tavaf MJ, Soltanmohammadi A, Zargarani S, Yazdanpanah E, Sadighimoghaddam B, Yousefi B, Sameni HR, Haghmorad D (2023) Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. Immun Inflamm Dis 11(1):e766","journal-title":"Immun Inflamm Dis"},{"issue":"10","key":"1901_CR114","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41590-021-01009-w","volume":"22","author":"S Tuzlak","year":"2021","unstructured":"Tuzlak S, Dejean AS, Iannacone M, Quintana FJ, Waisman A, Ginhoux F, Korn T, Becher B (2021) Repositioning TH cell polarization from single cytokines to complex help. Nat Immunol 22(10):1210\u20131217","journal-title":"Nat Immunol"},{"key":"1901_CR115","first-page":"1563","volume":"19","author":"KA Ullrich","year":"2020","unstructured":"Ullrich KA, Schulze LL, Paap E-M, M\u00fcller TM, Neurath MF, Zundler S (2020) Immunology of IL-12: an update on functional activities and implications for disease. EXCLI J 19:1563","journal-title":"EXCLI J"},{"issue":"12","key":"1901_CR116","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.4049\/jimmunol.176.12.7768","volume":"176","author":"A Vaknin-Dembinsky","year":"2006","unstructured":"Vaknin-Dembinsky A, Balashov K, Weiner HL (2006) IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 176(12):7768\u20137774","journal-title":"J Immunol"},{"key":"1901_CR117","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/jcm12051709","volume":"12","author":"J Van Schependom","year":"2023","unstructured":"Van Schependom J, D\u2019haeseleer M (2023) Advances in neurodegenerative diseases. J Clin Med 12:1709","journal-title":"J Clin Med"},{"issue":"3","key":"1901_CR118","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M, Dias D, Sebasti\u00e3o AM, Valente CA (2021) NLRP3 inflammasome: a starring role in amyloid-\u03b2-and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimers Dis 83(3):939\u2013961","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1901_CR119","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DA Vignali","year":"2012","unstructured":"Vignali DA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13(8):722\u2013728","journal-title":"Nat Immunol"},{"issue":"2","key":"1901_CR120","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1352458510384496","volume":"17","author":"TL Vollmer","year":"2011","unstructured":"Vollmer TL, Wynn DR, Alam MS, Valdes J (2011) A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis. Mult Scler 17(2):181\u2013191","journal-title":"Mult Scler"},{"issue":"12","key":"1901_CR121","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","volume":"18","author":"J vom Berg","year":"2012","unstructured":"vom Berg J, Prokop S, Miller KR, Obst J, K\u00e4lin RE, Lopategui-Cabezas I, Wegner A, Mair F, Schipke CG, Peters O, Winter Y, Becher B, Heppner FL (2012) Inhibition of IL-12\/IL-23 signaling reduces Alzheimer\u2019s disease\u2013like pathology and cognitive decline. Nat Med 18(12):1812\u20131819","journal-title":"Nat Med"},{"issue":"1","key":"1901_CR122","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12883-024-03918-3","volume":"24","author":"Y Wan","year":"2024","unstructured":"Wan Y, Zhao Y, Pan M, Gan J, Wu N, Zhang Y, Liu Z, Song L (2024) Peripheral biomarkers of Parkinson\u2019s disease and its correlation with clinical symptoms: a case-control study. BMC Neurol 24(1):417","journal-title":"BMC Neurol"},{"key":"1901_CR123","doi-asserted-by":"publisher","first-page":"112550","DOI":"10.1016\/j.fct.2021.112550","volume":"157","author":"T Wang","year":"2021","unstructured":"Wang T, Sun Q, Yang J, Wang G, Zhao F, Chen Y, Jin Y (2021) Reactive astrocytes induced by 2-chloroethanol modulate microglia polarization through IL-1\u03b2, TNF-\u03b1, and iNOS upregulation. Food Chem Toxicol 157:112550","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"1901_CR124","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","volume":"39","author":"R Wang","year":"2023","unstructured":"Wang R, Ren H, Kaznacheyeva E, Lu X, Wang G (2023a) Association of glial activation and \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurosci Bull 39(3):479\u2013490","journal-title":"Neurosci Bull"},{"key":"1901_CR125","doi-asserted-by":"publisher","first-page":"104643","DOI":"10.1016\/j.dci.2023.104643","volume":"141","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang A, Qiu X, Yang K, Zhou H (2023b) The IL-12 family cytokines in fish: molecular structure, expression profile and function. Dev Comp Immunol 141:104643","journal-title":"Dev Comp Immunol"},{"issue":"7","key":"1901_CR126","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.3390\/ijms26073106","volume":"26","author":"H Wang","year":"2025","unstructured":"Wang H, Ruan G, Li Y, Liu X (2025) The role and potential application of IL-12 in the immune regulation of tuberculosis. Int J Mol Sci 26(7):3106","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"1901_CR127","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jneuroim.2011.12.004","volume":"244","author":"S-R Wen","year":"2012","unstructured":"Wen S-R, Liu G-J, Feng R-N, Gong F-C, Zhong H, Duan S-R, Bi S (2012) Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 244(1\u20132):94\u201396","journal-title":"J Neuroimmunol"},{"key":"1901_CR128","doi-asserted-by":"publisher","first-page":"e073141","DOI":"10.1002\/alz.073141","volume":"19","author":"CN Winston","year":"2023","unstructured":"Winston CN, Rissman RA (2023) Exosomal IL-12p70 is increased in minority participants at risk for Alzheimer\u2019s disease. Alzheimers Dement 19:e073141","journal-title":"Alzheimers Dement"},{"key":"1901_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030268","author":"S Won","year":"2021","unstructured":"Won S, Ko JH, Jeon H, Park SS, Kim SN (2021) Co-administration of Gagam-Sipjeondaebo-Tang and ibuprofen alleviates the inflammatory response in MPTP-induced Parkinson\u2019s disease mouse model and RAW264.7 macrophages. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10030268","journal-title":"Pathogens"},{"key":"1901_CR130","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.clim.2021.108915","volume":"235","author":"D Wu","year":"2022","unstructured":"Wu D, Wang L, Hong D, Zheng C, Zeng Y, Ma H, Lin J, Chen J, Zheng R (2022) Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis. Clin Immunol 235:108915","journal-title":"Clin Immunol"},{"issue":"5","key":"1901_CR131","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/08923973.2022.2077755","volume":"44","author":"P Xiong","year":"2022","unstructured":"Xiong P, Liu T, Huang H, Yuan Y, Zhang W, Fu L, Chen Y (2022) IL-27 overexpression alleviates inflammatory response in allergic asthma by inhibiting Th9 differentiation and regulating Th1\/Th2 balance. Immunopharmacol Immunotoxicol 44(5):712\u2013718","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1901_CR132","doi-asserted-by":"publisher","first-page":"1366377","DOI":"10.3389\/fimmu.2024.1366377","volume":"15","author":"W-D Xu","year":"2024","unstructured":"Xu W-D, Wang D-C, Zhao M, Huang A-F (2024a) An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases. Front Immunol 15:1366377","journal-title":"Front Immunol"},{"issue":"1","key":"1901_CR133","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12672-024-01011-2","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu Y, Sun X, Tong Y (2024b) Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity. Discover Oncol 15(1):170","journal-title":"Discover Oncol"},{"key":"1901_CR134","doi-asserted-by":"publisher","first-page":"1514080","DOI":"10.3389\/fimmu.2025.1514080","volume":"16","author":"MK Yadav","year":"2025","unstructured":"Yadav MK, Singh SP, Egwuagu CE (2025) IL-6\/IL-12 superfamily of cytokines and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases. Front Immunol 16:1514080","journal-title":"Front Immunol"},{"key":"1901_CR135","first-page":"107","volume-title":"Role of IL-12\/IL-23 in the Pathogenesis of Multiple Sclerosis","author":"Y Yang","year":"2011","unstructured":"Yang Y, Lovett-Racke AE, Racke MK (2011) Role of IL-12\/IL-23 in the Pathogenesis of Multiple Sclerosis. Elsevier, Neuroinflammation, pp 107\u2013136"},{"issue":"4","key":"1901_CR136","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, Pruzin JJ, Fitzpatrick CD, Yau WYW, Kirn DR (2022) Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement 18(4):645\u2013653","journal-title":"Alzheimers Dement"},{"key":"1901_CR137","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fonc.2018.00114","volume":"8","author":"S Yasmin-Karim","year":"2018","unstructured":"Yasmin-Karim S, Moreau M, Mueller R, Sinha N, Dabney R, Herman A, Ngwa W (2018) Enhancing the therapeutic efficacy of cancer treatment with cannabinoids. Front Oncol 8:114","journal-title":"Front Oncol"},{"issue":"12","key":"1901_CR138","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/biom14121489","volume":"14","author":"E Yazdanpanah","year":"2024","unstructured":"Yazdanpanah E, Pazoki A, Dadfar S, Nemati MH, SajadSiadati SM, Tarahomi M, Orooji N, Haghmorad D, Oksenych V (2024) Interleukin-27 and autoimmune disorders: a compressive review of immunological functions. Biomolecules 14(12):1489","journal-title":"Biomolecules"},{"key":"1901_CR139","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphar.2020.00129","volume":"11","author":"J Ye","year":"2020","unstructured":"Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, Xu Y, Ye D, Zhang J, Lin Y (2020) Roles and mechanisms of interleukin-12 family members in cardiovascular diseases: opportunities and challenges. Front Pharmacol 11:129","journal-title":"Front Pharmacol"},{"issue":"11","key":"1901_CR140","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/jir.2021.0147","volume":"41","author":"C Ye","year":"2021","unstructured":"Ye C, Yano H, Workman CJ, Vignali DA (2021) Interleukin-35: structure, function and its impact on immune-related diseases. J Interferon Cytokine Res 41(11):391\u2013406","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"1901_CR141","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/1535-7163.MCT-23-0242","volume":"23","author":"P Yi","year":"2024","unstructured":"Yi P, Yu W, Xiong Y, Dong Y, Huang Q, Lin Y, Du Y, Hua F (2024) IL-35: new target for immunotherapy targeting the tumor microenvironment. Mol Cancer Ther 23(2):148\u2013158","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1901_CR142","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida H, Hunter CA (2015) The immunobiology of interleukin-27. Annu Rev Immunol 33(1):417\u2013443","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"1901_CR143","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3390\/biology12101307","volume":"12","author":"J You","year":"2023","unstructured":"You J, Youssef MM, Santos JR, Lee J, Park J (2023) Microglia and astrocytes in amyotrophic lateral sclerosis: disease-associated states, pathological roles, and therapeutic potential. Biology 12(10):1307","journal-title":"Biology"},{"issue":"12","key":"1901_CR144","doi-asserted-by":"publisher","first-page":"030006052097647","DOI":"10.1177\/0300060520976477","volume":"48","author":"J-J Zhu","year":"2020","unstructured":"Zhu J-J, Shan N-N (2020) Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia. J Int Med Res 48(12):0300060520976477","journal-title":"J Int Med Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01901-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01901-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01901-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:07:04Z","timestamp":1758085624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01901-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":144,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01901-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}